How to use these immunology viva questions

A viva tests whether you can explain a process aloud, organise the important steps, and respond when the examiner changes the question. Knowing a pathway is not enough if you cannot say where it starts, what it produces, and why the result matters.

The stations below cover three connected but distinct areas: immediate hypersensitivity, complement activation, and MHC-dependent antigen presentation. For each one, answer the opening question aloud before reading the model answer. Aim to make a complete explanation in a few minutes, then compare your response with the criteria and identify one detail to improve.

These are practice stations for biomedical science study, not a claim about a particular university’s viva format or marking rubric. If you are preparing for a specific course assessment, use your department’s guidance for its format and assessment criteria.

A practice examiner strip on an immunology board can focus on mechanisms and on how you connect them to evidence:

ExaminerImmunology viva practice
Mechanistic accuracyConnecting mechanisms to evidence
An illustrative examiner strip for practising immunology explanations, not an official assessment rubric.

Build a small bank of stations

For oral practice, organise topics as prompts rather than as chapter headings. “Complement” is too broad to rehearse as one answer. A useful station asks you to compare pathways, explain what they share, and interpret a consequence of a defect. That gives you a clear route through the answer and a way to notice omissions.

Include a mix of prompt types:

  • Explain a mechanism: what happens, in order, and which cells or molecules are involved?
  • Compare two processes: what is shared, and where do they diverge?
  • Apply a mechanism: what would a deficiency or laboratory result suggest?
  • Clarify a claim: does a positive test establish disease, or only one part of the evidence?

A board on this topic ends up looking like this:

StationAttemptsBestAvg
Immediate hypersensitivityExplain how an allergen can cause an immediate reaction on re-exposure. How would skin-prick testing differ from serum-specific IgE testing?37870
Complement pathwaysCompare the classical, lectin and alternative pathways. Where do they converge, and what are the main effector outcomes?27468
MHC antigen presentationCompare antigen presentation on MHC class I and class II, and explain one route by which an exogenous antigen can reach MHC class I.18176
Antibody class switchingExplain how an activated B cell changes antibody class while retaining antigen specificity.0——
An illustrative set of four oral stations generated from immunology revision topics, with one station still to attempt.

The first three stations are worked through below. The scores and comments in these practice recordings use MySummaries’ assessment dimensions, not a universal or official immunology-viva rubric. For your own course, substitute the criteria provided by your teaching team.

Station 1: Immediate hypersensitivity

Start with the sequence. A common weak answer jumps straight to histamine and misses sensitisation: how the first encounter prepares mast cells to respond later. Then distinguish sensitisation from clinically relevant allergy. A positive test can show allergen-specific IgE or reactivity without, by itself, proving that exposure causes symptoms.

A recorded attempt on this station can be reviewed against the steps that make the explanation complete:

Oral — Immediate hypersensitivityMarked

Examiner

Explain how an allergen can cause an immediate reaction on re-exposure. How would skin-prick testing differ from serum-specific IgE testing?

2:283:00Mark answer
78%Immediate hypersensitivity — marked78/100 · Developing · 2:28 spoken of 3:00
Sensitisation and IgE production16/20

You linked allergen exposure to a Th2 response and IgE production, but did not name IL-4 or IL-13 as signals promoting class switching.

ImproveState that Th2-derived IL-4 and IL-13 promote B-cell class switching to IgE.

Mast-cell activation and mediators17/20

You correctly described allergen cross-linking IgE on mast cells and release of histamine, but did not distinguish the immediate from the later response.

ImproveAdd lipid mediators to the immediate response and mention a later eosinophil-rich phase.

Testing and interpretation14/20

You distinguished an in-vivo skin test from a blood test, but treated a positive result as proof of clinical allergy.

ImproveExplain that either result supports sensitisation and must be interpreted with the exposure history.

A strong answerOn first exposure, antigen-presenting cells promote a type 2 response, and Th2 cytokines including IL-4 and IL-13 support B-cell class switching to allergen-specific IgE. IgE binds high-affinity FcεRI receptors on mast cells, sensitising them. On re-exposure, allergen cross-links cell-bound IgE and triggers mast-cell activation, with release of histamine and other mediators, including newly synthesised leukotrienes. A later inflammatory phase can involve eosinophils and other recruited cells. Skin-prick testing looks for an immediate local wheal-and-flare response, whereas serum-specific IgE measures allergen-specific IgE in blood; neither result alone proves that exposure causes clinical allergy.

An illustrative recorded practice answer on IgE-mediated hypersensitivity, scored against platform practice dimensions with a model response.

That is a MySummaries station, filled with immunology material. Yours is written from your own notes. Start free

Listen for whether you named the order correctly: Th2-associated signalling and IgE class switching, mast-cell sensitisation, then cross-linking on re-exposure. If you say “the allergen activates the mast cell” without describing the bound IgE, the mechanism is too compressed to show what recognises the allergen.

Also keep the tests distinct. Skin-prick testing is an in-vivo response in the skin; serum-specific IgE is an in-vitro measurement. Neither is interchangeable with a complete clinical diagnosis. If asked a follow-up about test interpretation, explain that sensitisation must be considered alongside the person’s history and the relevance of the allergen tested.

The transcript review should mark only the phrase that loses detail. The rest of the answer can remain intact; rewriting everything makes it harder to see the exact repair needed.

Transcript

On first exposure, a type 2 response supports production of allergen-specific IgE, which binds FcεRI on mast cells. When the allergen comes back, it activates the mast cells. They release histamine and other mediators, producing an immediate response. A skin test and a blood test can both be positive, so that confirms allergy.

not enough detail
When the allergen comes back, it activates the mast cells.

This skips the event that links recognition to activation: the allergen cross-links IgE already bound to FcεRI. Naming that step demonstrates the mechanism rather than just its outcome.

Say: On re-exposure, the allergen cross-links IgE bound to FcεRI on mast cells, triggering activation and mediator release.
An illustrative transcript review that identifies a compressed mechanism and a mistaken interpretation of test results.

A concise version of the correction is useful to rehearse: “On re-exposure, the allergen cross-links IgE bound to FcεRI.” Say it naturally, then repeat the full sequence without looking at the transcript.

Station 2: Complement pathways

This station rewards a comparative structure. Name the initiating recognition step for each pathway, then bring them together at C3. Avoid reciting a long list of components without saying what the pathways do. The key shared outcomes are opsonisation, inflammation and, through the terminal pathway, membrane attack complex formation.

A recorded attempt can show whether you distinguish pathway-specific activation from shared effector functions:

Oral — Complement pathwaysMarked

Examiner

Compare the classical, lectin and alternative pathways. Where do they converge, and what are the main effector outcomes?

2:413:00Mark answer
72%Complement pathways — marked72/100 · Developing · 2:41 spoken of 3:00
Pathway initiation and distinction15/20

You associated the classical route with antibody, but described the lectin and alternative routes too vaguely to distinguish their triggers.

ImproveName C1q recognition of antibody-bound targets, lectin recognition of microbial carbohydrates, and alternative-pathway amplification on surfaces.

Convergence at C315/20

You identified C3 cleavage but did not make clear that each pathway forms a C3 convertase.

ImproveState that pathway-specific C3 convertases cleave C3 to C3a and C3b.

Effector outcomes and application13/20

You named opsonisation and lysis, but did not connect C3a and C5a to inflammation or explain a relevant deficiency pattern.

ImproveAdd C3a/C5a inflammatory activity and one carefully qualified deficiency association.

A strong answerThe classical pathway is initiated when C1q recognises antibody bound to a target, while the lectin pathway begins when mannose-binding lectin or related recognition molecules bind microbial carbohydrates. The alternative pathway can be initiated by spontaneous C3 activation and is amplified on permissive surfaces. Each pathway forms a C3 convertase, which cleaves C3 into C3a and C3b. C3b opsonises targets and contributes to downstream convertase activity, while C3a and C5a promote inflammatory responses. The terminal pathway forms C5b-9, the membrane attack complex. Deficiency of terminal components is associated with increased susceptibility to Neisseria infections; C3 deficiency can cause severe recurrent infections because central opsonisation is impaired.

An illustrative recorded practice answer comparing complement activation, convergence and effector functions.

A useful answer map is: initiation → convertase → C3 products → terminal pathway → consequence of deficiency. For initiation, say that the classical pathway is commonly triggered by C1q binding to antibody-containing immune complexes; the lectin pathway recognises microbial carbohydrate patterns; and the alternative pathway provides surface-dependent amplification. Do not imply that every alternative-pathway event begins with a single, specific antibody-like recognition event.

At convergence, explain that the C3 convertases cleave C3. C3b is an opsonin and also supports progression towards C5 convertase formation. C3a and C5a are inflammatory mediators; C5b initiates assembly of C5b-9. The terminal complex can disrupt susceptible membranes.

For a deficiency follow-up, make the connection but avoid claiming that one infection pattern diagnoses a particular defect. Terminal component deficiency is associated with increased susceptibility to Neisseria, while C3 deficiency can impair opsonisation and lead to serious recurrent bacterial infections. If discussing a real result or patient, interpretation depends on the wider clinical and laboratory context.

If your answer runs out of time, prioritise the three pathway triggers and their shared C3 step. A catalogue of every component is less useful than a clear route through the mechanism.

Station 3: MHC antigen presentation

The central comparison is endogenous versus exogenous antigen processing, followed by the T-cell population that recognises each complex. A strong answer also shows that the division is not absolute: dendritic cells can cross-present some exogenous antigens on MHC class I.

A third recorded attempt can test whether the route, cell type and responding T-cell subset are linked clearly:

Oral — MHC antigen presentationMarked

Examiner

Compare antigen presentation on MHC class I and class II, and explain one route by which an exogenous antigen can reach MHC class I.

2:363:00Mark answer
81%MHC antigen presentation — marked81/100 · Strong · 2:36 spoken of 3:00
MHC class I processing and recognition17/20

You correctly described cytosolic protein processing and recognition by CD8 T cells, but did not mention TAP-mediated transport into the endoplasmic reticulum.

ImproveAdd that peptides are transported into the ER by TAP before loading onto MHC class I.

MHC class II processing and recognition17/20

You named professional antigen-presenting cells and CD4 T cells, but left out the invariant-chain/CLIP step.

ImproveBriefly explain that invariant chain blocks the groove, leaving CLIP until peptide exchange in the endosomal pathway.

Comparison and cross-presentation17/20

You explained cross-presentation by dendritic cells, but did not state why it matters for priming CD8 T cells against some exogenous antigens.

ImproveConnect cross-presentation to CD8 T-cell priming when the antigen was acquired from outside the presenting cell.

A strong answerMHC class I is expressed by almost all nucleated cells and usually presents peptides from cytosolic proteins. These proteins are degraded by the proteasome, and peptides enter the endoplasmic reticulum through TAP for loading onto MHC class I with β2-microglobulin; the complex is recognised by CD8 T cells. MHC class II is expressed mainly by professional antigen-presenting cells and presents peptides generated in endosomal compartments from material taken up from outside the cell. Invariant chain directs MHC class II through this route and blocks its peptide-binding groove; CLIP is later exchanged for antigenic peptide with the help of HLA-DM. The peptide–MHC class II complex is recognised by CD4 T cells. Dendritic cells can cross-present some exogenous antigens on MHC class I, helping prime CD8 T cells against those antigens.

An illustrative recorded practice answer comparing MHC class I and II processing and explaining cross-presentation.

A compact comparison works better than explaining the two routes as unrelated lists. For class I, connect cytosolic proteins to proteasomal degradation, TAP transport into the endoplasmic reticulum, peptide loading, and CD8 recognition. For class II, connect uptake of extracellular material to endosomal processing, invariant-chain handling, peptide loading and CD4 recognition.

Use “mainly” and “usually” where appropriate. MHC class I is broadly expressed on nucleated cells; MHC class II is concentrated on professional antigen-presenting cells, including dendritic cells, macrophages and B cells. Avoid saying that class I only ever presents self-derived material: cross-presentation is an important exception, particularly for dendritic-cell priming of CD8 T cells against antigens acquired from outside the cell.

If asked to explain CLIP, say that the invariant chain occupies the MHC class II peptide-binding groove during transport. It is degraded, leaving CLIP; HLA-DM facilitates exchange for antigenic peptide. You do not need to list every trafficking compartment unless the examiner asks for more detail.

Turn feedback into the next attempt

After each station, record one strength and one precise correction. “Learn complement better” is not an actionable review note. “I named C3b but forgot that C3a and C5a promote inflammation” identifies the gap and gives you a concrete retrieval cue.

Use this short review cycle:

  1. Answer once without notes. Keep the response within the station’s stated practice target, but do not rush through the mechanism.
  2. Compare the structure. Check whether you answered the whole question, including its comparison or application component.
  3. Repair one omission. Add the missing named molecule, step or qualification to a brief spoken answer.
  4. Return later. Reattempt the station after a gap rather than repeating it immediately until the wording is memorised.

A spoken debrief is most useful when it names a specific success and points towards the next improvement:

Spoken feedback

You linked TAP to class I peptide loading correctly; next, make the CLIP exchange step explicit in your class II explanation.

An illustrative spoken debrief that recognises a correct mechanism and gives one targeted next step.

The goal is not a memorised script. Learn the sequence and the relationships well enough to explain them in your own words, then adapt when a follow-up asks about a test, a deficiency or an exception.

How MySummaries helps

MySummaries lets you build an immunology revision board from your own PDFs, slides or photographed notes, then practise oral stations generated from that material. Record an answer, review the marked criteria and transcript, and turn repeated gaps into targeted revision. Start at portal.mysummaries.app.